Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailong Hu

Showing results (201-210 of 205) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 205 results.
European Urology Oncology|May 18, 2024
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder CancerZhouliang Wu, Gangjian Zhao, Zhe Zhang, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2021
Urinary Single-Cell Profiling Captures the Cellular Diversity of the KidneyAmin Abedini, Yuan O Zhu, Shatakshee Chatterjee, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world studyCheoklong Ng, Taile Jing, Shicheng Yu, et al.
International Journal of Surgery (London, England)|May 24, 2024
The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registriesLilong Liu, Kaiwen Li, Shao-Gang Wang, et al.
Science (New York, N.Y.)|February 6, 2025
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variantsHongbo Liu, Amin Abedini, Eunji Ha, et al.
Pageof 21

Showing results (201-210 of 205) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 205 results.
European Urology Oncology|May 18, 2024
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder CancerZhouliang Wu, Gangjian Zhao, Zhe Zhang, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2021
Urinary Single-Cell Profiling Captures the Cellular Diversity of the KidneyAmin Abedini, Yuan O Zhu, Shatakshee Chatterjee, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world studyCheoklong Ng, Taile Jing, Shicheng Yu, et al.
International Journal of Surgery (London, England)|May 24, 2024
The prognostic impact of tumor location in nonmuscle-invasive bladder cancer patients undergoing transurethral resection: insights from a cohort study utilizing Chinese multicenter and SEER registriesLilong Liu, Kaiwen Li, Shao-Gang Wang, et al.
Science (New York, N.Y.)|February 6, 2025
Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variantsHongbo Liu, Amin Abedini, Eunji Ha, et al.
Pageof 21